Related Experiment Video
Updated: May 16, 2026

Murine Model of Intestinal Ischemia-reperfusion Injury
Published on: May 11, 2016
Which pathways trigger the role of complement in ischaemia/reperfusion injury?
Conrad A Farrar1, Elham Asgari, Wilhelm J Schwaeble
1MRC Centre for Transplantation, Division of Transplantation Immunology and Mucosal Biology, King's College London School of Medicine at Guy's, King's College and St Thomas' Hospitals London, UK.
Complement activation drives ischemia/reperfusion (I/R) injury via C3 cleavage, with the lectin pathway emerging as a key mediator across different organs. Understanding these mechanisms is crucial for developing targeted therapies.
Area of Science:
- Immunology
- Nephrology
- Pathology
Background:
- Ischemia/reperfusion (I/R) injury involves complement system activation, leading to C3 cleavage and formation of C5a and C5b-9.
- C3 synthesized within the ischemic kidney plays a significant role in I/R injury.
- The precise mechanisms of complement activation and their organ-specific triggers in I/R injury remain incompletely understood.
Purpose of the Study:
- To review recent evidence on the roles of the classical, lectin, and alternative complement pathways in mediating I/R injury.
- To highlight the significance of the lectin pathway in various organ models of I/R injury.
- To explore novel complement activation routes contributing to organ damage.
Main Methods:
- Literature review of studies investigating complement activation in I/R injury.
- Analysis of evidence for the involvement of classical, lectin, and alternative pathways.
- Focus on organ-specific mechanisms and lectin-dependent pathways.
Main Results:
- Common effector mechanisms in I/R injury involve C3 cleavage, producing C5a and C5b-9.
- The lectin pathway appears to be a central mediator of I/R injury across different organs.
- Unusual complement activation routes contributing to organ damage have been identified.
Conclusions:
- Complement activation, particularly via the lectin pathway, is a critical factor in I/R injury.
- Understanding organ-specific complement activation mechanisms is essential for developing targeted therapeutic strategies.
- Further research into novel activation pathways may reveal new therapeutic targets for limiting I/R injury while preserving complement function.
More Related Videos
07:05Visualization of Neutrophil Extracellular Traps in Mesenteric Venules After Mesenteric Ischemia-Reperfusion Injury via Intravital Microscopy
Published on: September 27, 2024
09:53Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
Published on: January 10, 2025
Related Concept Videos
Complement System
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Acute Inflammation III: Local and Systemic Effects
Ischemic Stroke ll: Pathophysiology
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...